NO127579B - - Google Patents
Download PDFInfo
- Publication number
- NO127579B NO127579B NO02603/69A NO260369A NO127579B NO 127579 B NO127579 B NO 127579B NO 02603/69 A NO02603/69 A NO 02603/69A NO 260369 A NO260369 A NO 260369A NO 127579 B NO127579 B NO 127579B
- Authority
- NO
- Norway
- Prior art keywords
- formula
- methyl
- phenyl
- denotes
- compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 10
- 150000001412 amines Chemical class 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- -1 alkali metal salt Chemical class 0.000 claims description 5
- 229910052736 halogen Inorganic materials 0.000 claims description 5
- 230000001225 therapeutic effect Effects 0.000 claims description 5
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 4
- 150000001266 acyl halides Chemical class 0.000 claims description 4
- 150000002367 halogens Chemical class 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- 150000008065 acid anhydrides Chemical class 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 150000001721 carbon Chemical group 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 239000012442 inert solvent Substances 0.000 claims description 2
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 claims description 2
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 2
- 125000003762 3,4-dimethoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C(OC([H])([H])[H])C([H])=C1* 0.000 claims 1
- 210000003323 beak Anatomy 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 36
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 16
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- 239000000047 product Substances 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000010992 reflux Methods 0.000 description 9
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- IJUIPRDMWWBTTQ-UHFFFAOYSA-N 3-phenyl-1h-pyridazin-6-one Chemical compound N1C(=O)C=CC(C=2C=CC=CC=2)=N1 IJUIPRDMWWBTTQ-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001447 alkali salts Chemical class 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 229960005475 antiinfective agent Drugs 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- KAZPHAGSWZTKDW-UHFFFAOYSA-N 1-(3,4-dimethoxyphenyl)propan-2-amine Chemical compound COC1=CC=C(CC(C)N)C=C1OC KAZPHAGSWZTKDW-UHFFFAOYSA-N 0.000 description 1
- HEKMSRLHSLEVMF-UHFFFAOYSA-N 3-(4-methoxyphenyl)-1h-pyridazin-6-one Chemical compound C1=CC(OC)=CC=C1C1=NNC(=O)C=C1 HEKMSRLHSLEVMF-UHFFFAOYSA-N 0.000 description 1
- GXCQEJABMXDVRC-UHFFFAOYSA-N 3-ethyl-1h-pyridazin-6-one Chemical compound CCC1=CC=C(O)N=N1 GXCQEJABMXDVRC-UHFFFAOYSA-N 0.000 description 1
- QZWIXLPWMGHDDD-UHFFFAOYSA-N 3-methyl-1h-pyridazin-6-one Chemical compound CC1=CC=C(O)N=N1 QZWIXLPWMGHDDD-UHFFFAOYSA-N 0.000 description 1
- 229910018072 Al 2 O 3 Inorganic materials 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 206010048873 Traumatic arthritis Diseases 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007665 chronic toxicity Effects 0.000 description 1
- 231100000160 chronic toxicity Toxicity 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 229910000039 hydrogen halide Inorganic materials 0.000 description 1
- 239000012433 hydrogen halide Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 208000030428 polyarticular arthritis Diseases 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000003192 teratological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES355900A ES355900A1 (es) | 1968-06-27 | 1968-06-27 | Procedimiento para la obtencion de compuestos de la serie de la piridazona. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO127579B true NO127579B (es) | 1973-07-16 |
Family
ID=8449665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO02603/69A NO127579B (es) | 1968-06-27 | 1969-06-23 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US3657243A (es) |
| AT (1) | AT292008B (es) |
| BE (1) | BE735187A (es) |
| BR (1) | BR6910146D0 (es) |
| CH (1) | CH502349A (es) |
| DE (1) | DE1926895A1 (es) |
| DO (1) | DOP1970001739A (es) |
| ES (1) | ES355900A1 (es) |
| FR (1) | FR2011731A1 (es) |
| GB (1) | GB1265209A (es) |
| LU (1) | LU58896A1 (es) |
| NL (1) | NL6909905A (es) |
| NO (1) | NO127579B (es) |
| SE (1) | SE352358B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4279908A (en) * | 1979-04-19 | 1981-07-21 | Sankyo Company Limited | Pyridazine derivatives and their use as agricultural fungicides |
| US4242512A (en) * | 1979-08-06 | 1980-12-30 | Morishita Pharmaceutical Co., Ltd. | Novel thioamide derivatives containing a pyridazine group |
| US4503056A (en) * | 1982-03-02 | 1985-03-05 | Abbott Laboratories | 1-(Pyridazinyl)pyrazoline derivatives |
| US4945091A (en) * | 1987-07-30 | 1990-07-31 | Nissan Chemical Industries, Ltd. | 3(2H)-pyridazinone compounds derivatives and compositions for controlling and/or preventing insect pests intermediates for such compounds, and a process for their manufacture |
| US7601856B2 (en) * | 2006-07-27 | 2009-10-13 | Wyeth | Benzofurans as potassium ion channel modulators |
| US7662831B2 (en) * | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
| CN102584853B (zh) * | 2011-12-14 | 2014-08-13 | 伊犁川宁生物技术有限公司 | 一种7-苯乙酰氨基去乙酰氧基头孢烷酸的制备方法 |
-
1968
- 1968-06-27 ES ES355900A patent/ES355900A1/es not_active Expired
-
1969
- 1969-05-27 DE DE19691926895 patent/DE1926895A1/de active Pending
- 1969-06-06 CH CH867469A patent/CH502349A/fr not_active IP Right Cessation
- 1969-06-18 LU LU58896D patent/LU58896A1/xx unknown
- 1969-06-20 US US835215A patent/US3657243A/en not_active Expired - Lifetime
- 1969-06-23 NO NO02603/69A patent/NO127579B/no unknown
- 1969-06-24 FR FR6921094A patent/FR2011731A1/fr not_active Withdrawn
- 1969-06-25 BR BR210146/69A patent/BR6910146D0/pt unknown
- 1969-06-25 GB GB1265209D patent/GB1265209A/en not_active Expired
- 1969-06-26 AT AT06086/69A patent/AT292008B/de not_active IP Right Cessation
- 1969-06-26 SE SE09056/69A patent/SE352358B/xx unknown
- 1969-06-26 BE BE735187D patent/BE735187A/xx unknown
- 1969-06-27 NL NL6909905A patent/NL6909905A/xx unknown
-
1970
- 1970-07-30 DO DO1970001739A patent/DOP1970001739A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE1926895A1 (de) | 1970-01-02 |
| NL6909905A (es) | 1969-12-30 |
| FR2011731A1 (es) | 1970-03-06 |
| ES355900A1 (es) | 1969-12-16 |
| US3657243A (en) | 1972-04-18 |
| BE735187A (es) | 1969-12-01 |
| LU58896A1 (es) | 1969-11-12 |
| BR6910146D0 (pt) | 1973-02-08 |
| GB1265209A (es) | 1972-03-01 |
| CH502349A (fr) | 1971-01-31 |
| DOP1970001739A (es) | 1972-02-09 |
| SE352358B (es) | 1972-12-27 |
| AT292008B (de) | 1971-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0004011B1 (de) | Phenoxyalkylcarbonsäure-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
| US4113871A (en) | Hypoglycemically and hypolipidemically active derivatives of phenyl-alkane-carboxylic acids | |
| US3852338A (en) | N-substituted phenylalanine derivatives | |
| Bhat et al. | Synthesis of novel thioureido derivatives of sulfonamides and thiosemicarbazido derivatives of coumarin as potential anticonvulsant and analgesic agents | |
| US2493710A (en) | Carbamic acid esters | |
| JPH03218367A (ja) | ナフチルオキサゾリドン誘導体、その製法及びその合成中間体 | |
| PL95166B1 (es) | ||
| FR2565587A1 (fr) | Derive nouveau de diamide d'amino-acide a caractere acide n-acylique, un sel de celui-ci, un procede de production de celui-ci et un agent anti-ulcereux le contenant | |
| NO127579B (es) | ||
| JPS61109766A (ja) | アダマンタンアミン誘導体、その製造方法及びそれを含む医薬 | |
| SU776559A3 (ru) | Способ получени рацемических или оптически активных производных 1,4бензодиазепин-2-она | |
| JPH0215067A (ja) | イソキノリンスルホンアミド誘導体 | |
| NO761050L (es) | ||
| SU955860A3 (ru) | Способ получени производных 3-амино-1-бензоксепин-5/2н/-она или их солей | |
| JPS6045878B2 (ja) | Ｎ，ｎ’−二置換環状ジアミン及び精神病治療用薬剤 | |
| US3953449A (en) | 2-(4-M-CF3 or -SCF3 phenylpiperazino)-ethyl benzoates | |
| US3846476A (en) | N-benzyloxycarbonyl-dopa derivatives | |
| Miller | Derivatives of (-)-trans-2, 3-epoxysuccinic acid and some of their biological effects | |
| US3637804A (en) | Phenylalanine derivatives and preparation thereof | |
| US3988371A (en) | Meta-[2-(benzylamino)-ethyl] benzoic acid amides | |
| DK141749B (da) | Analogifremgangsmåde til fremstilling af pyridincarboxamidoethylbenzensulfonylurinstof-forbindelser. | |
| SE426593B (sv) | Sett att framstella 1,3-disubstituerade karbamider och 2-tiokarbamider | |
| FI60863C (fi) | Foerfarande foer framstaellning av nya bentshydryloxialkylaminderivat med foerlaengd antihistamineffekt | |
| JP2861274B2 (ja) | アミノケトン誘導体 | |
| EP0134763B1 (en) | 1-methyl-5-p-methylbenzoylpyrrole-2-acetamidoacetanilides with anti-inflammatory, analgesic, antipyretic and antiplatelet aggregant activity |